Category Archives: The Charlton Centre

World IBD Day

Posted on May 19, 2022 by admin

Inflammatory bowel disease (IBD) describes both Crohn’s disease and ulcerative colitis. Both are chronic inflammatory diseases of the gut. People who have these diseases have symptoms that include but are not limited to, diarrhea, bleeding from the rectum, pain, and … Continue reading →

Posted in The Charlton Centre | Leave a comment

Shingrix Awareness

Posted on May 5, 2022 by admin

Many health professionals will be selecting a week in May to promote the prevention of shingles through a Shingrix Awareness Week. Shingrix is a vaccine for the prevention of shingles (Herpes Zoster). It is given as a series of 2 … Continue reading →

Posted in The Charlton Centre | Leave a comment

Paxlovid© Information

Posted on April 20, 2022 by admin

Recently we have been receiving several questions from our patients about the new COVID medication Paxlovid©. Given that we are currently in the 6th COVID-19 wave, we thought it was important to clarify who qualifies and how to access Paxlovid© … Continue reading →

Posted in The Charlton Centre | Leave a comment

Celebrating International Pompe Day

Posted on April 6, 2022 by admin

International Pompe Day is April 15. We would like to celebrate this day by raising more awareness for those who are living with Pompe Disease and help others understand the challenges they face.  It is also a very exciting time … Continue reading →

Posted in The Charlton Centre | Leave a comment

Charlton Masking Policy

Posted on March 23, 2022 by admin

Although the Government of Ontario removed mandatory masking requirements for most indoor settings March 21, 2022, this does not apply to healthcare settings. Mandatory masking requirements remain in effect for settings such as public transit, healthcare settings, long-term care homes, … Continue reading →

Posted in The Charlton Centre | Leave a comment

Health Canada Approves Three New Adalimumab Biosimilars

Posted on March 10, 2022 by admin

A year ago (March 10, 2021) we posted about adalimumab having five biosimilars, we are happy to say that number has increased to eight! There are eight biosimilars approved by Health Canada now. The original adalimumab is Humira (Abbvie), and … Continue reading →

Posted in The Charlton Centre | Leave a comment

Management of Psoriasis

Posted on February 24, 2022 by admin

As a follow-up to our previous blog about the newly approved treatment for patients with psoriasis, we would like to share useful tips regarding lifestyle and healthy skincare. It is important to note that although these tips may help you … Continue reading →

Posted in The Charlton Centre | Leave a comment

New Psoriasis Treatment Option

Posted on February 9, 2022 by admin

Psoriasis is an autoimmune condition resulting in chronic inflammation of the skin affecting roughly 1 million Canadians. Mild to moderate cases of psoriasis may be managed through topical treatments (e.g. creams, ointments, gels, foams) like corticosteroids, Vitamin D3 analogues, retinoids, … Continue reading →

Posted in The Charlton Centre | Leave a comment

Mental Health: Fighting the Stigma

Posted on January 26, 2022 by admin

We have spoken many times on our blog about the importance of mental health and how those living with chronic illness often experience mental health concerns at a higher rate. We know throughout the pandemic, these challenges have been amplified … Continue reading →

Posted in The Charlton Centre | Leave a comment

Working Towards New Therapies for Sjogren’s Syndrome

Posted on January 12, 2022 by admin

With the ongoing development of new advanced therapies (e.g. biologics and small molecule medications), most patients are able to achieve a low level of disease activity for many of the commonly occurring autoimmune diseases (e.g. rheumatoid arthritis, ankylosing spondylitis, psoriasis). … Continue reading →

Posted in The Charlton Centre | Leave a comment